Cellseed Inc.

Cellseed Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY55.75
Market Cap
JPY12.01 B
Shares Outstanding
11.43 M
Public Float
10.35 M

Profile

Address
Telecom Center Building, 15/F
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cellseed.com
Updated 09/14/2018
CellSeed Inc. develops regenerative medicine products. Its operations are carried out through the following business divisions: Cell Sheet Regenerative Medicine and Intelligent Cell Culture Ware Products. The Cell Sheet Regenerative Medicine division provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

Financials

View All
Created with Highcharts 5.0.14Cellseed Inc.Net Income. Fiscal year is January-December. All values JPY Thousands.584 588584 588582 699582 699535 253535 2531 414 2551 414 255966 474966 474201320142015201620170250k500k750k1 000k1 250k1 500k
Created with Highcharts 5.0.14Cellseed Inc.Sales/Revenue. Fiscal year is January-December. All values JPY Thousands.105 769105 76986 32586 325193 118193 118100 673100 67385 06185 06120132014201520162017050k100k150k200k250k

Setsuko Hashimoto
President, CEO & Representative Director
Jun Onodera
CFO, Director & Manager-Corporate Planning